We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+11.66%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
10 Year Est. Return
AUM
$572M
AUM Growth
+$505M
Cap. Flow
+$466M
Cap. Flow %
81.59%
Top 10 Hldgs %
75.29%
Holding
570
New
76
Increased
157
Reduced
78
Closed
237

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.22M
2
BIIB icon
Biogen
BIIB
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.04M
4
ROST icon
Ross Stores
ROST
+$1.53M
5
MNST icon
Monster Beverage
MNST
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 7.26%
2 Industrials 3.12%
3 Communication Services 2.93%
4 Financials 2.5%
5 Consumer Discretionary 2.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COOP
226
DELISTED
Mr. Cooper
COOP
$25.1K ﹤0.01%
+386
New +$22.8K
HCC icon
227
Warrior Met Coal
HCC
$4.73B
$24.8K ﹤0.01%
+407
New +$21.5K
GSHD icon
228
Goosehead Insurance
GSHD
$2.37B
$24.8K ﹤0.01%
327
+321
+5,350% +$23.2K
CVSA
229
Covista Inc
CVSA
$4.23B
$24.2K ﹤0.01%
+410
New +$21.9K
DBRG icon
230
DigitalBridge
DBRG
$2.95B
$24K ﹤0.01%
+1,368
New +$22.5K
HCI icon
231
HCI Group
HCI
$2.31B
$23.9K ﹤0.01%
+273
New +$20K
ZWS icon
232
Zurn Elkay Water Solutions
ZWS
$8.6B
$23.7K ﹤0.01%
+807
New +$22.9K
CRS icon
233
Carpenter Technology
CRS
$27.7B
$23.7K ﹤0.01%
335
-168
-33% -$11.3K
TNET icon
234
TriNet
TNET
$3.06B
$23.4K ﹤0.01%
197
+168
+579% +$19.2K
LRN icon
235
Stride
LRN
$3.32B
$23.3K ﹤0.01%
+392
New +$21.5K
KAI icon
236
Kadant
KAI
$3.95B
$23.3K ﹤0.01%
+83
New +$20.8K
LBRT icon
237
Liberty Energy
LBRT
$3.27B
$22.5K ﹤0.01%
+1,239
New +$23.5K
INTC icon
238
Intel
INTC
$503B
$18.6K ﹤0.01%
371
+331
+828% +$13.4K
SPGI icon
239
S&P Global
SPGI
$119B
$15.9K ﹤0.01%
36
+18
+100% +$7.1K
BBY icon
240
Best Buy
BBY
$16.9B
$15.4K ﹤0.01%
197
+146
+286% +$10.3K
TMUS icon
241
T-Mobile US
TMUS
$193B
$15.2K ﹤0.01%
95
+64
+206% +$9.47K
MNST icon
242
Monster Beverage
MNST
$92.1B
$15K ﹤0.01%
261
-28,546
-99% -$1.53M
ANSS
243
DELISTED
Ansys
ANSS
$14.9K ﹤0.01%
41
-661
-94% -$196K
IDXX icon
244
Idexx Laboratories
IDXX
$46.5B
$14.4K ﹤0.01%
26
-383
-94% -$180K
ISRG icon
245
Intuitive Surgical
ISRG
$132B
$14.2K ﹤0.01%
42
-658
-94% -$196K
PEG icon
246
Public Service Enterprise Group
PEG
$37.4B
$13K ﹤0.01%
+212
New +$13K
HUM icon
247
Humana
HUM
$44.1B
$12.8K ﹤0.01%
28
+20
+250% +$9.86K
DXCM icon
248
DexCom
DXCM
$31.3B
$12.5K ﹤0.01%
101
-4
-4% -$409
AZN icon
249
AstraZeneca
AZN
$250B
$11.3K ﹤0.01%
84
CSGP icon
250
CoStar Group
CSGP
$12B
$10.9K ﹤0.01%
125
-11
-8% -$890

Similar funds

USA Financial Formulas's Q4 2023 Portfolio in Review

As of Q4 2023, USA Financial Formulas held 570 positions worth $572M, up 754% from $66.9M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

USA Financial Formulas deployed $466M of net new capital in Q4 2023, opening 76 new positions and adding to 157 existing holdings. Its largest new stake was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.

By sector, the portfolio is most concentrated in Technology at 7.3% of assets, down from 17% a quarter earlier, followed by Industrials and Communication Services.

On the sell side, the largest reduction was Biogen, an estimated $2.09M trimmed.

  • USA Financial Formulas's largest Q4 2023 buy was iShares S&P 500 Growth ETF: 855,439 shares worth $64.2M.
  • USA Financial Formulas added most to iShares S&P Mid-Cap 400 Growth ETF in Q4 2023, an estimated $61.8M increase.
  • USA Financial Formulas's biggest Q4 2023 reduction was Biogen, cutting an estimated $2.09M.
  • USA Financial Formulas fully exited Regeneron Pharmaceuticals in Q4 2023, selling an estimated $2.22M.
  • USA Financial Formulas's ten largest holdings make up 75% of its $572M portfolio in Q4 2023.
  • USA Financial Formulas opened 76 new positions and closed 237 in Q4 2023.
  • USA Financial Formulas's portfolio value rose 754% quarter-over-quarter to $572M.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.